These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA- cp rat model of the metabolic syndrome. Lu J; Borthwick F; Hassanali Z; Wang Y; Mangat R; Ruth M; Shi D; Jaeschke A; Russell JC; Field CJ; Proctor SD; Vine DF Br J Nutr; 2011 Jun; 105(11):1572-82. PubMed ID: 21276281 [TBL] [Abstract][Full Text] [Related]
24. Effects of oleic-rich and omega-3-rich diets on serum lipid pattern and lipid oxidation in mildly hypercholesterolemic patients. Puiggrós C; Chacón P; Armadans LI; Clapés J; Planas M Clin Nutr; 2002 Feb; 21(1):79-87. PubMed ID: 11884017 [TBL] [Abstract][Full Text] [Related]
25. Clustering of metabolic disorders and hyperinsulinemia in Mexico City. Zamora-González J; Yamamoto-Kimura L; Lerman-Garber I; Cardoso-Saldaña G; Fajardo-Gutierrez A; Posadas-Romero C Int J Obes Relat Metab Disord; 1996 Apr; 20(4):311-8. PubMed ID: 8680457 [TBL] [Abstract][Full Text] [Related]
26. Dietary fat intake, body composition and blood lipids of university men and women. Neville MM; Geppert J; Min Y; Grimble G; Crawford MA; Ghebremeskel K Nutr Health; 2012 Jul; 21(3):173-85. PubMed ID: 23533205 [TBL] [Abstract][Full Text] [Related]
27. Responses of LDL and HDL particle size and distribution to omega-3 fatty acid supplementation and aerobic exercise. Wooten JS; Biggerstaff KD; Ben-Ezra V J Appl Physiol (1985); 2009 Sep; 107(3):794-800. PubMed ID: 19589957 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of n-3 long chain polyunsaturated fatty acids and fenofibrate on markers of inflammation and vascular function, and on the serum lipoprotein profile in overweight and obese subjects. Bragt MC; Mensink RP Nutr Metab Cardiovasc Dis; 2012 Nov; 22(11):966-73. PubMed ID: 21429719 [TBL] [Abstract][Full Text] [Related]
29. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension. Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156 [TBL] [Abstract][Full Text] [Related]
30. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome. Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374 [TBL] [Abstract][Full Text] [Related]
31. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma. Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528 [TBL] [Abstract][Full Text] [Related]
32. Dietary fatty acids and lipoprotein metabolism: new insights and updates. Ooi EM; Ng TW; Watts GF; Barrett PH Curr Opin Lipidol; 2013 Jun; 24(3):192-7. PubMed ID: 23619368 [TBL] [Abstract][Full Text] [Related]
33. Association between different dietary polyphenol subclasses and the improvement in cardiometabolic risk factors: evidence from a randomized controlled clinical trial. Vetrani C; Vitale M; Bozzetto L; Della Pepa G; Cocozza S; Costabile G; Mangione A; Cipriano P; Annuzzi G; Rivellese AA Acta Diabetol; 2018 Feb; 55(2):149-153. PubMed ID: 29151225 [TBL] [Abstract][Full Text] [Related]
34. Plasma lipidomic profiles after a low and high glycemic load dietary pattern in a randomized controlled crossover feeding study. Dibay Moghadam S; Navarro SL; Shojaie A; Randolph TW; Bettcher LF; Le CB; Hullar MA; Kratz M; Neuhouser ML; Lampe PD; Raftery D; Lampe JW Metabolomics; 2020 Nov; 16(12):121. PubMed ID: 33219392 [TBL] [Abstract][Full Text] [Related]
35. Effects of short- and long-term Mediterranean-based dietary treatment on plasma LC-QTOF/MS metabolic profiling of subjects with metabolic syndrome features: The Metabolic Syndrome Reduction in Navarra (RESMENA) randomized controlled trial. Bondia-Pons I; Martinez JA; de la Iglesia R; Lopez-Legarrea P; Poutanen K; Hanhineva K; Zulet Mde L Mol Nutr Food Res; 2015 Apr; 59(4):711-28. PubMed ID: 25641909 [TBL] [Abstract][Full Text] [Related]
36. n-3 PUFA and caloric restriction diet alters lipidomic profiles in obese men with metabolic syndrome: a preliminary open study. Shabrina A; Tung TH; Nguyen NTK; Lee HC; Wu HT; Wang W; Huang SY Eur J Nutr; 2020 Oct; 59(7):3103-3112. PubMed ID: 31865423 [TBL] [Abstract][Full Text] [Related]
37. Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study. Lambert C; Cubedo J; Padró T; Sánchez-Hernández J; Antonijoan RM; Perez A; Badimon L Nutrients; 2017 Jun; 9(6):. PubMed ID: 28608804 [TBL] [Abstract][Full Text] [Related]
38. Reduction in cardiometabolic risk factors by a multifunctional diet is mediated via several branches of metabolism as evidenced by nontargeted metabolite profiling approach. Tovar J; de Mello VD; Nilsson A; Johansson M; Paananen J; Lehtonen M; Hanhineva K; Björck I Mol Nutr Food Res; 2017 Feb; 61(2):. PubMed ID: 27670644 [TBL] [Abstract][Full Text] [Related]
39. Fatty fish intake decreases lipids related to inflammation and insulin signaling--a lipidomics approach. Lankinen M; Schwab U; Erkkilä A; Seppänen-Laakso T; Hannila ML; Mussalo H; Lehto S; Uusitupa M; Gylling H; Oresic M PLoS One; 2009; 4(4):e5258. PubMed ID: 19390588 [TBL] [Abstract][Full Text] [Related]
40. An Oily Fish Diet Improves Subclinical Inflammation in People at High Cardiovascular Risk: A Randomized Controlled Study. Costabile G; Della Pepa G; Vetrani C; Vitaglione P; Griffo E; Giacco R; Vitale M; Salamone D; Rivellese AA; Annuzzi G; Bozzetto L Molecules; 2021 Jun; 26(11):. PubMed ID: 34199645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]